QuantRx Biomedical Corporation announced that William Fleming, its President, Chief Scientific Officer and a director, unexpectedly passed away on March 21, 2015. The Board of Directors is currently searching for a successor to manage the Company as it executes is business plan. In the interim, the company will be managed by its Chief Executive Officer, with assistance from its Board of Directors and outside advisors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.004 USD | -.--% | -.--% | -49.37% |
1st Jan change | Capi. | |
---|---|---|
-49.37% | 315K | |
+8.69% | 219B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 108B | |
+0.27% | 63.06B | |
+12.72% | 52.02B | |
+3.96% | 48.2B | |
+0.40% | 40.37B | |
+15.03% | 39.35B |
- Stock Market
- Equities
- QTXB Stock
- News QuantRx Biomedical Corporation
- QuantRx Biomedical Corporation Announces Demise of William Fleming, President, Chief Scientific Officer and Director